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Actinomycetoma in SE Asia: the first case from
Laos and a review of the literature
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Jacques Gubler4, Mayfong Mayxay1,5,6, Rattanaphone Phetsouvanh1,6, Ivo Elliott1,6, Julie Logan7, Robert Hill8,
Paul N Newton1,6 and David Dance1,6*
Abstract
Background: Mycetoma is a chronic, localized, slowly progressing infection of the cutaneous and subcutaneous
tissues caused either by fungi (eumycetoma or implantation mycosis) or by aerobic actinomycetes
(actinomycetoma). It is acquired by traumatic implantation, most commonly in the tropics and subtropics, especially
in rural agricultural communities. Although well recognized elsewhere in Asia, it has not been reported from the
Lao People’s Democratic Republic (Laos).
Case presentation: A 30 year-old female elementary school teacher and rice farmer from northeast Laos was
admitted to Mahosot Hospital, Vientiane, with a massive growth on her left foot, without a history of trauma. The
swelling had progressed slowly but painlessly over 5 years and multiple draining sinuses had developed. Ten days
before admission the foot had increased considerably in size and became very painful, with multiple sinuses and
discharge, preventing her from walking. Gram stain and bacterial culture of tissue biopsies revealed a branching
filamentous Gram-positive bacterium that was subsequently identified as Actinomadura madurae by 16S rRNA gene
amplification and sequencing. She was treated with long-term co-trimoxazole and multiple 3-week cycles of
amikacin with a good therapeutic response.
Conclusion: We report the first patient with actinomycetoma from Laos. The disease should be considered in the
differential diagnosis of chronic skin and bone infections in patients from rural SE Asia.
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Background
Mycetoma, commonly known as Madura foot, is a
chronic, localized, slowly progressive, granulomatous in-
fection of the deep dermis and subcutaneous tissue
caused either by fungi (eumycetoma or implantation my-
cosis) or by aerobic actinomycetes (actinomycetoma) [1].
It was first described in India by Gill in 1842 and the
term mycetoma was first used by Carter in 1860 [1,2].
Mycetoma occurs unevenly worldwide but is endemic in
tropical and sub-tropical regions, particularly between
latitudes 15° S and 30° N, known as the ‘Mycetoma belt’.
The belt includes Sudan, Somalia, Senegal, India, Yemen,
Mexico, Venezuela, Colombia and Argentina. In Sudan,
1231 cases were reported within a 2.5-year period and it
was found to be the third commonest cause of amputa-
tion [3,4]. Cases imported from endemic areas are occa-
sionally seen in temperate countries [5].
More than 20 species of bacteria and fungi have been
identified as aetiologic agents of mycetoma: approxi-
mately 60% of cases are due to bacteria and 40% are
caused by fungi. The predominant cause varies geograph-
ically, probably because of environmental factors [6]. In
India, Mexico and Brazil, actinomycetoma is the most
common but in Sudan most cases are implantation my-
coses. The agents most often responsible for causing
actinomycetoma are Actinomadura madurae, Actinoma-
dura pelletieri, Nocardia brasiliensis and Streptomyces
somaliensis. Madurella mycetomatis, M. grisea and
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Pseudallescheria boydii are the most common causes of
implantation mycoses [7-11]. Actinomycetoma tends to
progress more rapidly, with greater inflammation and tis-
sue destruction and earlier invasion of bone than im-
plantation mycosis. Initially, the patient may feel pain or
discomfort at the inoculated site. After traumatic inocu-
lation, painless subcutaneous nodules slowly develop and
spread. Later, the nodules increase in size and quantity
with accompanying sinuses that drain serous, sero-
sanguineous or purulent fluid [12]. The main route of in-
fection is uncertain but, as organisms are usually present
in the soil [13], it is likely that they are implanted into
the host tissue by traumatic inoculation such as thorn
pricks or splinters, although only half of the patients can
remember a history of trauma preceding the disease [7].
This theory is supported by the facts that cases are com-
mon among farmers, herdsmen, field labourers or people
walking bare foot and that the main affected areas are
foot and hand, although other parts may be involved less
frequently [12,14-16]. The incubation period is variable,
from three months to nine years in natural infections.
Since the mean duration before the first medical evalu-
ation is five years, patient recall of trauma may often be
unreliable [7,17].
Mycetoma is more common in males than females,
with an overall sex ratio of 3:1, possibly relating to dif-
ferences in occupational and other outdoor activities
rather than gender differences in susceptibility [11,15].
The condition is also commonest in young adults
(16–40 years old) [9].
Irrespective of the causative agent, the clinical presen-
tation is similar, with tissue swelling and draining sinuses
that usually discharge visible grains. It is important to
determine the causative agent of mycetoma in order to
choose the appropriate treatment. The colour of the
grains in the discharge from the sinuses may be helpful
for presumptive identification of the aetiology, although
this is not entirely reliable. Black grains are said to be
associated with Madurella mycetomatis, Madurella grisea,
Exophiala jeanselmei, Curvularia species, Leptosphaeria
species and Pyrenochaeta species, white grains with
Nocardia species, Actinomadura madurae, Pseudal-
lescheria boydii, Acremonium species, Cylindrocarpon spe-
cies and Fusarium species, yellow grains with Streptomyces
somaliensis and red with Actinomadura pelletieri [3,14].
Differential diagnosis includes soft tissue tumours such as
lipoma, fibroma, sarcoma, malignant melanoma and
chronic osteomyelitis caused by pyogenic bacteria or myco-
bacteria, and other mycoses such as chromoblastomycosis,
lobomycosis, paracoccidioidomycosis, phaeohyphomycosis
and sporotrichosis [18].
Although cases have been reported from neighbouring
countries, mycetoma has never been reported in Laos:
we report here the first case.
Case presentation
An otherwise healthy 30-year-old female elementary school
teacher and rice farmer from Namun village (19.6552435°
N, 103.5781784° E), Kham District, Xiengkhuang Province,
northeast Laos, presented to Mahosot Hospital in October
2011 with tumefaction, pain and multiple draining sinuses
on her left foot. The lesion had started 5 years previously,
initially with an uncomfortable feeling and itching on the
left plantar surface that over a few days became indurated
and developed a spontaneously draining sinus. She remem-
bered no specific injury to her foot. Over the next five
years, the lesion slowly and painlessly progressed, with
swelling and multiple draining sinuses. Ten days before ad-
mission she developed acute swelling of the foot with se-
vere pain associated with multiple sinuses and discharge
from the foot that prevented her from walking. Foot X-ray
done at a local hospital showed signs of osteolysis of the
left metatarsal bones. With a diagnosis of chronic osteo-
myelitis of the left foot she was treated with oral cloxacillin
for a few days, but when branching Gram positive rods
were demonstrated on a Gram stain of an aspirate from
the lesion at the provincial hospital she was transferred to
Mahosot Hospital. On examination, she was orientated,
afebrile with normal vital signs, and physical examination
was unremarkable except for a massive tumour-like lesion
of the left foot with multiple sinuses on the dorsal and
plantar surfaces. The overlying skin was moderately ery-
thematous and was tender and painful on palpation with
evidence of a sero-sanguinous discharge containing no ob-
vious grains (Figures 1 and 2). There was no regional
lymphadenopathy or lymphangitis present. Admission la-
boratory investigation (normal ranges in parentheses)
revealed a total white blood cell count of 6.1 × 109/L (6.0-
8.0 × 109/L), 68% neutrophils (45-70%), haematocrit 28%
(37-47%), haemoglobin 75 g/L (120–160 g/L), mean corpus-
cular volume 59 fL (80-95fL), platelets 449 × 109/L (150-300
Figure 1 Left foot of the patient showing classic features of
mycetoma: tumefaction, sinus tracts and discharge.
Rattanavong et al. BMC Infectious Diseases 2012, 12:349 Page 2 of 6
http://www.biomedcentral.com/1471-2334/12/349
× 109/L), creatinine 72 μmol/L (53-120 μmol/L), urea 4.3
mmol/L (5.3-16 mmol/L), aspartate transaminase 50 U/L
(0–37 U/L), alanine transaminase 34 U/L (0–45 U/L) and
blood glucose 4.2 mmol/L (4.1- 6.4 mmol/L). A radiograph
of the left foot confirmed partial osteolysis of the metatarsal
bones (Figure 3). Four 3 mm diameter tissue biopsies were
taken from her left foot under local anaesthesia. Smears
from these samples underwent microscopy after Gram stain,
Ziehl-Neelsen stain and the 20% potassium hydroxide tech-
nique. The samples were cultured aerobically on blood,
chocolate, MacConkey, Sabouraud and Ashdown’s agars
and were submitted for mycobacterial culture and histo-
pathology. The Gram stain revealed scanty branching
filamentous Gram positive bacteria (Figure 4), which
grew after 5 days’ incubation on chocolate and blood
agar. She was presumptively diagnosed as suffering from
actinomycetoma and started on amikacin (15 mg/kg/
day) combined with trimethoprim-sulfamethoxazole (7/
35 mg/kg/day), both in two daily doses. One biopsy
sample, which had been immediately frozen at −80°C,
and the organism were both identified by 16S rRNA
amplification and sequencing as Actinomadura
madurae (Figure 5) by the Health Protection Agency
(HPA), UK [19]. Broth dilution MICs for the organism,
performed by the HPA, gave the following results (mg/l):
amikacin ≤ 0.25 (S), gentamicin 2 (S), tobramycin ≤ 0.25
(S), amoxicillin/clavulanate 4 (S), cefotaxime 4, ceftriaxone
0.25 (S), imipenem ≤ 0.125 (S), meropenem 0.5 (S), co-
trimoxazole 0.032 (S), clarithromycin 4 (I), ciprofloxacin ≤
0.25 (S), moxifloxacin ≤ 0.25 (S) and doxycycline ≤ 0.25
(S). After 21 days of intravenous amikacin and oral tri-
methoprim-sulfamethoxazole, the patient’s left foot
showed some evidence of healing with decreasing pain,
swelling and discharge without any side effects from treat-
ment. She was transferred for further treatment at a dis-
trict hospital close to her home. On the basis of published
recommendations, amikacin was given for sequential
cycles of 3 weeks with 2 week breaks, and trimethoprim-
sulfamethoxazole was continued throughout: creatinine
and hearing were monitored weekly without abnormalities
[20,21]. After 5 cycles of treatment there had been a
marked reduction in swelling (Figures 6 and 7), consider-
able symptomatic improvement, and the patient was able
to walk and to return to teaching. The patient continued
on oral co-trimoxazole alone until a total of 12 months of
treatment had been completed, at which stage she had no
pain at rest and there were no sinuses or discharge from
the foot, although there was still considerable residual
bony abnormality evident radiologically (Figure 8).
Our patient represents a fairly typical, albeit severe,
case of actinomycetoma caused by A. madurae, with in-
volvement of the underlying bone. Bone involvement is
Figure 2 Left foot of the patient showing classic features of
mycetoma: tumefaction, sinus tracts and discharge.
Figure 3 X-ray of the left foot showing sign of destruction of
the metatarsal bones.
Figure 4 Gram stain of smear from left foot tissue biopsy
revealed branching, filamentous Gram positive bacteria.
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common in advanced stages of the disease (an incidence
of 73% was reported in one series), leading to deformity
and disability of the affected area [22].
Even a classic clinical presentation and typical colours of
grains in mycetoma does not reliably distinguish actinomy-
cetoma from implantation mycosis, so laboratory investi-
gations, including microscopy, histology and extended
cultures are indicated. Other investigations including fine
needle aspiration cytology, imaging (X-ray, magnetic reson-
ance and ultrasound), sero-diagnosis (counter-immuno-
electrophoresis and ELISA) and molecular detection and
identification may also be useful [14,18]. Although the evi-
dence base is poor, without clinical trials, combined treat-
ment with multiple antibiotics is usually recommended in
order to prevent drug resistance and eradicate any residual
infection. Reported cure rates vary widely ranging from
60% to 90%. Sulphonamides and sulphonamide combina-
tions are recommended as the first line treatment. Amino-
glycosides, tetracyclines, rifampicin, ciprofloxacin and
amoxicillin-clavulanate have also been used successfully.
The combination of amikacin and co-trimoxazole, the
former given in cycles, has produced excellent clinical
results, especially in those at risk of pulmonary spread or
vertebral involvement [21]. Five to ten cycles may be
needed to achieve cure. Furthermore, surgery may be con-
sidered for small lesions, infections that fail to respond to
antibiotics and to help medical treatment by reduction of
the infective load or deal with life-threatening lesions
[12,14,18,20].
This is the first case of mycetoma reported from Laos.
Cases have been reported infrequently from Southeast Asia,
the majority of which has a prolonged rainy season unlike
Figure 5 Unrooted tree of Actinomadura spp. partial 16S rRNA sequences (bases ~1200 bp, accession numbers after species name).
Figure 6 Left foot of the patient after 5 cycles of amikacin
showing considerable resolution of swelling and healing of
sinus tracts.
Figure 7 Left foot of the patient after 5 cycles of amikacin
showing considerable resolution of swelling and healing of
sinus tracts.
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the arid regions usually associated with mycetoma.
Mycetoma has, however, been reported from Singapore,
Malaysia, Philippines, Indonesia, Cambodia, Thailand and
Vietnam. Table 1 shows cases identified by searching
PubMed using the terms ‘Mycetoma’AND ‘Southeast Asia’
or ‘Mycetoma’ AND the names of individual countries
(‘Lao’, ‘Thai’, ‘Cambodia’, ‘Burma’, ‘Myanmar’, ‘Malaysia’,
‘Singapore’, ‘Indo’, ‘Philip’, ‘Timor’, ‘Brunei’, ‘Vietnam’). The true
incidence in the region, however, is unknown.
Conclusions
This patient confirms the existence of mycetoma caused
by Actinomadura madurae in Laos. Approximately 78%
of the Lao population works mainly in agriculture and
there are, as elsewhere in the rural tropics, few micro-
biology laboratories, making it likely that the condition
is under-diagnosed. Isolation of the causative organism
enabled medical treatment, which almost certainly saved
this young woman from amputation and lifelong disabil-
ity. Mycetoma should be considered in the differential
diagnosis of chronic skin and bone infections in Laos
and elsewhere in Southeast Asia.
Consent
Written informed consent was obtained from the patient
for publication of this Case report and any accompanying
Figure 8 X-ray of the left foot after 1 year of treatment
showing considerable residual bony abnormalities.
Table 1 Summary of reports of Mycetoma in Southeast Asia
Country Year Patients Diagnosis Organism1 Reference
Singapore 1967 1 Histology Monosporium apiospermum [23]
Malaysia 1968 1 Histology and
culture
Phialophora jeanselmei [24]
1969 1 Histology Madurella mycetomi [25]
1982 1 Histology and
culture
Streptomyces somaliensis [26]
Philippines 1960 1 Culture Madurella grisea [27]
1965 1 Histology and
culture
Madurella grisea [28]
Indonesia 1938 1 Culture Madurella tropicana [29]
1978 14 NA2 NA [30]
Cambodia 1963 1 Histology and
culture
Pyrenochaeta romeroi [31]
1965 1 Grains and
radiography
Madura mycetes [32]
Thailand 1981 17 Histology and
culture
Nocardia asteroides (6 cases); N. caviae (2 cases); N. brasiliensis (2 cases); N. rosatii (1 case);
Madurella mycetomii (3 cases); A. boydii (1 case); P. jeanselmei (1 case) and Strep. madurae
(1 case).
[33]
1994-
1997
14 Histology and
culture
Only one case was confirmed by culture as Cladosporium carrionii [34]
Vietnam 1973 1 Culture Nocardia otitidiscaviarum [35]
NOTES
1. The nomenclature used in the original publications has been retained. In several cases this was a presumptive identification based on histology alone.
2. NA: not available.
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images. A copy of the written consent is available for re-
view from the Series Editor of this journal.
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